Adam McBride | Source | CEO at Eden
Adam McBride
Adam McBride is the CEO and co-founder of Eden, a healthcare platform on a mission to make metabolic health more accessible, sustainable, and empowering. His journey is personal, after struggling with his own health and losing 60 pounds using GLP-1 therapies, Adam built Eden with Josh Khan, to help others access the tools and care he wished he had years earlier.
Adam’s path hasn’t been linear. Raised in a tight-knit Mormon community, he’s since stepped away from that faith, driven by a desire to forge his own path in life and business. After corporate roles at Capital One and GEICO, and the tragic loss of his sister to weight-related health issues, Adam channeled his experience into building Eden: a company where science, empathy, and action come together.
He’s a Harvard graduate, a father of four, an endurance athlete, and a passionate advocate for changing how we approach health. Adam’s philosophy is simple: “I want people to wake up feeling like they’re 18 again.” His leadership is driven by purpose, principles, and a deep belief that people deserve better options, and real support—to live vibrant, energetic lives.
-
Eden (https://www.tryeden.com/)
CEO
started Jun 2024
-
Eden Moves Beyond Telehealth With 'Sanctuary of Wellness' Club
Telehealth platform Eden is expanding to off-line experiences with its first luxury wellness club, set to open in Colorado.
Article -
Ozempic: Sale of Compounded Versions of Some Weight Loss Drugs to End
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.
Article
-
U.S. vs. Europe: Unraveling the Obesity Rate Disparity
Adam explains, “The gap in obesity rates comes down to diet, lifestyle, and healthcare approach.” Europe favors whole foods and active lifestyles, while the U.S. leans on processed foods and reactive healthcare. Eden aims to shift this by promoting proactive metabolic health solutions. -
Eden CEO Warns Against Unsupervised Use of Longevity Supplements
Adam highlights the dangers of unsupervised peptide use, noting their potential to accelerate aging. He stresses the importance of medical guidance, citing risks like "unknown efficacy" and quality control issues. Adam advises consumers to seek expert advice, verify scientific backing, and prioritize safety. Eden's commitment to transparency and evidence-based solutions sets them apart in the unregulated supplement market.
-
Healthcare is undergoing a radical transformation, and the hottest benefits in the year to come will be those that challenge the status quo. Traditional health insurance is failing us—it’s expensive, inefficient, and reactive rather than preventative. Employees are taking control by opting for out-of-pocket solutions like compounded GLP-1 medications, which are not only more affordable than their insurance premiums but also offer preventative health benefits that save costs in the long run.
